Panobinostat in myelofibrosis - 101793

Spotlight
Video

Panobinostat in myelofibrosis

VJHemOnc has 872 videos Subscribe Here

Loading........
Description: Claire Harrison, MD of the Guy's and St. Thomas Hospital in London, UK, talks about panobinostat (LBH589), commonly used for the treatment of multiple myeloma, which is now being assessed in myelofibrosis (MF). Panobinostat in combination with ruxolitinib, has been shown to be efficacious and safe for the treatment of myelofibrosis. Other important markers also demonstrated the promising effects of this combinations, such as a 35% reduction in spleen volume and early delivery of changes in bone marrow morphology.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL.
Shared By : VJHemOnc
Posted on : 02/08/16
Added : 2 years ago



Recommended

Nothing found.

More From VJHemOnc

Nothing found.